The VEINS Meeting (@theveinsatviva) 's Twitter Profile
The VEINS Meeting

@theveinsatviva

The Venous Endovascular INterventional Strategies Course; A comprehensive analysis on #AcuteVenous and #ChronicVenous diseases. RT/Follow≠Endorsement

ID: 2459859612

linkhttps://viva-foundation.org/ calendar_today23-04-2014 15:07:30

838 Tweet

873 Followers

280 Following

Varshana Gurusamy (@drvarshana) 's Twitter Profile Photo

Truly thankful/honored to sit on the panel amongst giants in the field of venous disease. Great discussion and audience participation even at 8am! šŸ’ŖšŸ½

Surmodics, Inc. (@surmodics) 's Twitter Profile Photo

Thank you to everyone who joined Drs. Nachiket Patel and Vinod Chainani at the Pounceā„¢ Venous #Thrombectomy System break session The VEINS Meeting! Rx only. #TheVEINS24 #VIVA2024

Thank you to everyone who joined Drs. Nachiket Patel and Vinod Chainani at the Pounceā„¢ Venous #Thrombectomy System break session <a href="/TheVEINSatVIVA/">The VEINS Meeting</a>! Rx only. #TheVEINS24 #VIVA2024
The VIVA Foundation (@vivaphysicians) 's Twitter Profile Photo

This Morning:Ā  The VEINS Blue Sky Breakfast continues our tradition of presenting tech from cutting-edge medical device companies:Ā  Ā Inari MedicalĀ  Ā Inquis MedicalĀ  Ā InterVeneĀ  Ā SonoVascularĀ  Ā Akura Medical

This Morning:Ā 

The VEINS Blue Sky Breakfast continues our tradition of presenting tech from cutting-edge medical device companies:Ā 

Ā Inari MedicalĀ 
Ā Inquis MedicalĀ 
Ā InterVeneĀ 
Ā SonoVascularĀ 
Ā Akura Medical
Venous News (@venousnews) 's Twitter Profile Photo

#TheVEINS24: The VEINS Innovation Summit hears about emerging thrombectomy technologies, including the latest on SonoThrombectomy, currently undergoing first-in-human study in South America. The VIVA Foundation

#TheVEINS24: The VEINS Innovation Summit hears about emerging thrombectomy technologies, including the latest on SonoThrombectomy, currently undergoing first-in-human study in South America. <a href="/VIVAPhysicians/">The VIVA Foundation</a>
The VIVA Foundation (@vivaphysicians) 's Twitter Profile Photo

#TheVEINS24 Late-Breaking Clinical Trial session is underway! Late-breaking clinical trial data summaries are now available: viva-foundation.org/news-article?i… Thank you to today’s presenters and panelists.

The VIVA Foundation (@vivaphysicians) 's Twitter Profile Photo

The inaugural PE Summit kicks off this afternoon at #TheVEINS24 and #VIVA24. Experts will discuss the technologies and issues surrounding the treatment of intermediate to high-risk PE. Virtual registration is still available here - viva-foundation.org/register

The inaugural PE Summit kicks off this afternoon at #TheVEINS24 and #VIVA24. 

Experts will discuss the technologies and issues surrounding the treatment of intermediate to high-risk PE.

Virtual registration is still available here - viva-foundation.org/register
The VIVA Foundation (@vivaphysicians) 's Twitter Profile Photo

The VIVA Foundation is pleased to announce the appointment of Dr. Kush R. Desai to The VIVA Foundation Board of Directors. We are excited to have his expertise, passion, and leadership join us. Congratulations, Dr. Kush Desai!

The VIVA Foundation is pleased to announce the appointment of Dr. Kush R. Desai to The VIVA Foundation Board of Directors. 

We are excited to have his expertise, passion, and leadership join us. 

Congratulations, Dr. <a href="/kush_r_desai/">Kush Desai</a>!
The VIVA Foundation (@vivaphysicians) 's Twitter Profile Photo

Missed #VIVA24? Watch this featured session for free: Improving Vascular Care for the Disadvantaged Experts examined care variations across patient populations, combatting biases, & how we can move toward a better future for all patients. youtu.be/eYJ3I3_a7O4?si…

The VEINS Meeting (@theveinsatviva) 's Twitter Profile Photo

Late-breaking data presented at #TheVEINS24 by Dr. Julie Bulman: Clot Burden Reduction With a Novel Thrombectomy Device for the Treatment of Acute Pulmonary Embolism: RV/LV ratio and MMS Reductions Observed in the Pilot ENGULF Trial youtube.com/watch?v=pgw5rv…

The VEINS Meeting (@theveinsatviva) 's Twitter Profile Photo

Every year, VIVA and The VEINSĀ feature groundbreaking and clinically significant data presentations. This year,Ā we are sharing a late-breaking clinical trial presentation fromĀ our 2024 conferences each week. See this week's featured presentation here:

The VEINS Meeting (@theveinsatviva) 's Twitter Profile Photo

ICYMI at #TheVEINS24: Randomized Controlled Trial Comparing Cyanoacrylate Closure to Surgical Stripping: Spectrum Program Secondary Outcomes Through 6 Months presented by Manj Gohel, MD youtu.be/NsuGn3KFfJU Manj Gohel

The VIVA Foundation (@vivaphysicians) 's Twitter Profile Photo

REGISTER NOW Free Webinar Wednesday 5/21, 8pm ET / 5pm PT Data Deep Dive: The Latest Insights from STRIDE-PAD and SOUL Register here: viva-foundation.org/webinar-regist…

REGISTER NOW
Free Webinar 
Wednesday 5/21, 8pm ET / 5pm PT

Data Deep Dive: The Latest Insights from STRIDE-PAD and SOUL

Register here: viva-foundation.org/webinar-regist…
The VIVA Foundation (@vivaphysicians) 's Twitter Profile Photo

Data from the STRIDE and SOUL studies have demonstrated the potential of semaglutide to transform the treatment landscape for patients with PAD. Join the lead authors + vascular experts THIS WEEK for a deep dive into these findings. Register now: viva-foundation.org/webinar-regist…

Data from the STRIDE and SOUL studies have demonstrated the potential of semaglutide to transform the treatment landscape for patients with PAD.

Join the lead authors + vascular experts THIS WEEK for a deep dive into these findings.

Register now: viva-foundation.org/webinar-regist…
The VIVA Foundation (@vivaphysicians) 's Twitter Profile Photo

Registration is now open for #VIVA25 and #TheVEINS25! Join us at VIVA and The VEINS for a dynamic, multidisciplinary experience. Register now: viva-foundation.org/register

Registration is now open for #VIVA25 and #TheVEINS25! 

Join us at VIVA and The VEINS for a dynamic, multidisciplinary experience. 

Register now: viva-foundation.org/register
The VIVA Foundation (@vivaphysicians) 's Twitter Profile Photo

šŸ”„Controversy in Vascular Care! In this clip from our recent Data Deep Dive, Dr. Marc Bonaca shares new STRIDE-PAD findings, leading to a spirited conversation on semaglutide, real-world limitations, and the complexity of treatment decisions. Watch here: youtube.com/watch?v=GE6fNR…

šŸ”„Controversy in Vascular Care!

In this clip from our recent Data Deep Dive, Dr. Marc Bonaca shares new STRIDE-PAD findings, leading to a spirited conversation on semaglutide, real-world limitations, and the complexity of treatment decisions.

Watch here: youtube.com/watch?v=GE6fNR…
The VIVA Foundation (@vivaphysicians) 's Twitter Profile Photo

2 new opportunities for early-career physicians (<5 yrs post-training): 1 - Apply for a scholarship! Apps for the #VIVA25 Early Career Leadership Program close July 10 OR 2 - Register for VIVA & The VEINS 2025 with special discounted rates Learn more: viva-foundation.org/viva1

2 new opportunities for early-career physicians (&lt;5 yrs post-training):

1 - Apply for a scholarship! Apps for the #VIVA25 Early Career Leadership Program close July 10

OR

2 - Register for VIVA &amp; The VEINS 2025 with special discounted rates

Learn more: viva-foundation.org/viva1
The VIVA Foundation (@vivaphysicians) 's Twitter Profile Photo

Join us this fall for #VIVA25 and #TheVEINS25, the ultimate multidisciplinary educational experiences in vascular care. Register now - viva-foundation.org/register Register for both #VIVA25 and #TheVEINS25 for $ off tuition (Physicians, PAs/NPs, and Nurses/Techs/HCPs only)

Join us this fall for #VIVA25 and #TheVEINS25, the ultimate multidisciplinary educational experiences in vascular care.

Register now - viva-foundation.org/register

Register for both #VIVA25 and #TheVEINS25 for $ off tuition (Physicians, PAs/NPs, and Nurses/Techs/HCPs only)